Tuesday, June 30, 2026

JW Pharmaceutical Secures U.S. Patent for Hair Loss Drug Candidate JW0061

JW Pharmaceutical secures a U.S. patent for hair loss treatment JW0061, targeting GFRA1 receptor, ensuring market exclusivity until 2039.

Seoul St. Mary’s Hospital Reaches 20,000 Robotic Surgeries, Marking New Clinical Milestone

Seoul St. Mary's Hospital celebrates 20,000 robotic surgeries, enhancing patient care with advanced single-port techniques for various conditions.

Tag: MSCI

Samsung Epis Holdings Earns MSCI AA Rating in First Global ESG Assessment

Samsung Epis Holdings earns an AA ESG rating from MSCI, highlighting its commitment to sustainable management and biopharmaceutical growth.

Top News

- Our Sponsors Ad -

Follow us